News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Vaccines news

Show

From To
Vaccines
Shingles vaccine is safe, according to new study

The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine.

Published
23 April 2012
From
Eurekalert Medicine & Health
Vaccines
Possible clues found to why HIV vaccine showed modest protection

Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine.

Published
04 April 2012
From
Eurekalert Inf Dis
How HIV works
HIV 'superinfection' boosts immune response: Findings may provide insight into HIV-vaccine development

Women who have been infected by two different strains of HIV from two different sexual partners – a condition known as HIV superinfection – have more potent antibody responses that block the replication of the virus compared to women who’ve only been infected once.

Published
30 March 2012
From
Science Daily
Vaccines
Inovio Pharmaceuticals' PENNVAX®-B HIV Vaccine Demonstrates Strong T-Cell Immune Responses in Therapeutic Vaccine Trial

Significant T-cell responses against multiple HIV antigens demonstrate potential of Inovio's synthetic vaccines for HIV therapy.

Published
14 March 2012
From
Manual Items
Vaccines
Zostavax Shingles Vaccine Generally Safe, Increases Antibody Levels, in People With Stable HIV

Two doses of Zostavax, a vaccine against shingles (herpes zoster), administered six weeks apart is “generally safe” for people living with HIV with CD4 counts of 200 or higher and undetectable viral loads, according to study results shared Wednesday, March 7, at the 19th Conference on Retroviruses and Opportunistic Infections (CROI).

Published
12 March 2012
From
AIDSMeds
How HIV causes disease
Superinfection: second HIV infections happen as often as first ones

Two studies of people with HIV in Rakai, Uganda and Mombasa, Kenya presented at the 19th Conference on Retroviruses and Opportunistic Infections show that the rate at

Published
10 March 2012
By
Gus Cairns
What is HIV?
Deeper view of HIV reveals impact of early mutations

Mutations in HIV that develop during the first few weeks of infection may play a critical role in undermining a successful early immune response, a finding that reveals the importance of vaccines targeting regions of the virus that are less likely to mutate.

Published
09 March 2012
From
Science Daily (press release)
Vaccines
GeoVax Labs Presents New Findings on Potential HIV Vaccine

Study Suggests Scientists May Be One Step Closer to a Vaccine That Protects Against Multiple Exposures to HIV Infections

Published
07 March 2012
From
Market Watch
New and experimental HIV treatments
Norwegian HIV vaccine—Very modest results seen in recent clinical trial

The Norwegian biotechnology company Bionor Pharma ASA recently issued a press release about the results of its candidate therapeutic vaccine called Vacc-4x. The placebo-controlled study was conducted to assess safety and preliminary efficacy in HIV-positive people. Researchers had hoped that this vaccine would allow participants to have a prolonged interruption of ART with very low levels of virus in their blood. This did not happen. However, the vaccine is safe and does stimulate the immune system.

Published
22 February 2012
From
CATIE
Vaccines
Results for viral load on Vacc-4x

With final review of phase IIb viral load data completed, researchers confirm statistically significant reduction of HIV viral load on Vacc-4x compared to placebo

Published
16 February 2012
From
Bionor Pharma
← Prev1...34567...21Next →

Filter by country